Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Satoshi, Fukagawa"'
Autor:
Chihiro Kiyoshima, Naoto Shirasu, Daichi Urushiyama, Satoshi Fukagawa, Toyofumi Hirakawa, Kenichi Yoshikawa, Daisuke Izuchi, Kohei Miyata, Masamitsu Kurakazu, Fusanori Yotsumoto, Kenji Hiromatsu, Makoto Nomiyama, Ohta Eiji, Shinichi Hirose, Yoshitoshi Ogura, Tetsuya Hayashi, Kenichiro Hata, Kazuki Nabeshima, Shin'ichiro Yasunaga, Shingo Miyamoto
Publikováno v:
Future Science OA, Vol 7, Iss 5 (2021)
Background: This study was performed to investigate the clinical significance of miR-4535 and miR-1915-5p in severe chorioamnionitis. Materials & methods: Amniotic fluid samples from 37 patients with severe chorioamnionitis were subjected to miRNA ar
Externí odkaz:
https://doaj.org/article/8f6f2654fcab4e06b58443d1e79bc8c0
Autor:
Kenichi Yoshikawa, Shin'ichiro Yasunaga, Takashi Setoue, Shingo Miyamoto, Makoto Nomiyama, Daichi Urushiyama, Shinichiro Nagamitsu, Masamitsu Kurakazu, Ayako Sanui, Kenichiro Hata, Toyofumi Hirakawa, Daisuke Izuchi, Kohei Miyata, Kazuki Nabeshima, Satoshi Fukagawa, Chihiro Kiyoshima
Publikováno v:
Placenta. 114:68-75
Clinical prediction of foetal inflammatory response syndrome (FIRS) is highly necessary. We have previously reported that miR-4535 and miR-1915-5p are potential biomarkers for severe chorioamnionitis based on the results of microRNA array analysis. T
Autor:
Ryota Araki, Kazuki Nabeshima, Fusanori Yotsumoto, Koichi Shigekawa, Satoshi Fukagawa, Ayako Sanui, Masamitsu Kurakazu, Masaharu Murata, Daichi Urushiyama, Hisatomi Arima, Kenichi Yoshikawa, Kohei Miyata, Toyofumi Hirakawa, Chihiro Kiyoshima, Daisuke Izuchi, Mariko Kurakazu, Shingo Miyamoto
Publikováno v:
Placenta. 80:4-7
Introduction This study was performed to determine whether the combination of maternal blood and amniotic fluid biomarkers can improve the predictive accuracy of histologic chorioamnionitis (HC). Methods This retrospective study included 80 singleton
Autor:
Shinichi Hirose, Ohta Eiji, Yoshitoshi Ogura, Chihiro Kiyoshima, Kohei Miyata, Kenji Hiromatsu, Kenichi Yoshikawa, Kazuki Nabeshima, Shin'ichiro Yasunaga, Naoto Shirasu, Daisuke Izuchi, Masamitsu Kurakazu, Satoshi Fukagawa, Fusanori Yotsumoto, Tetsuya Hayashi, Kenichiro Hata, Makoto Nomiyama, Toyofumi Hirakawa, Shingo Miyamoto, Daichi Urushiyama
Publikováno v:
Future Science OA
Background: This study was performed to investigate the clinical significance of miR-4535 and miR-1915-5p in severe chorioamnionitis. Materials & methods: Amniotic fluid samples from 37 patients with severe chorioamnionitis were subjected to miRNA ar
Autor:
Daisuke Miyahara, Nam Sung Ouk, Toyofumi Hirakawa, Chihiro Kiyoshima, Daisuke Izuchi, Kohei Miyata, Koichiro Shigekawa, Fusanori Yotsumoto, Ayako Sanui, Masamitsu Kurakazu, Ryota Araki, Masaharu Murata, Kyoko Shirota, Satoshi Fukagawa, Tomohiro Ito, Hiroko Ito, Shingo Miyamoto, Takahiro Katsuda, Masahide Kuroki, Daichi Urushiyama, Kenichi Yoshikawa, Shin'ichiro Yasunaga
Publikováno v:
Anticancer Research. 38:4347-4351
Background/aim Many anticancer agents including molecularly-targeted drugs have been developed for ovarian cancer. However, the prognosis of recurrent ovarian cancer remains extremely poor. Heparin-binding epidermal growth factor-like growth factor (
Autor:
Masaharu Murata, Hiroshi Yagi, Kyoko Shirota, Satoshi Fukagawa, Shingo Miyamoto, Chihiro Kiyoshima, Kiyoko Kato, Haruchika Anan, Shin'ichiro Yasunaga, Kohei Miyata, Daisuke Miyahara, Sung Ouk Nam, Takahiro Katsuda, Fusanori Yotsumoto
Publikováno v:
Cancer Science
Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly targeted therapy,
Autor:
Sung Ouk Nam, Shingo Miyamoto, Masahide Kuroki, Kohei Miyata, Hiromi Yamada, Satoshi Fukagawa, Fusanori Yotsumoto
Publikováno v:
Cancer Medicine
Colorectal cancer (CRC) is one of the most frequently occurring cancers with high morbidity and mortality worldwide. Amphiregulin (AREG), a member of the epidermal growth factor family and a rational target for CRC therapy, is essential for the three
Autor:
Daisuke Miyahara, Satoshi Fukagawa, Shin'ichiro Yasunaga, Takahiro Katsuda, Kohei Miyata, Sung Ouk Nam, Takashi Odawara, Fusanori Yotsumoto, Toyokazu Ishikawa, Shingo Miyamoto, Sadao Manabe
Publikováno v:
Anticancer Research. 37
Advanced lung cancer is one of the most lethal malignancies. Many anticancer agents have been developed for lung cancer with epidermal growth factor receptor (EGFR) mutations, but its prognosis remains extremely poor. The development of molecularly-t
Autor:
Sadao Manabe, Toyokazu Ishikawa, Shin'ichiro Yasunaga, Satoshi Fukagawa, Fusanori Yotsumoto, Shingo Miyamoto, Takashi Odawara
Publikováno v:
Anticancer research. 37(7)
Background Patients with ovarian cancer with high levels of heparin-binding epidermal growth factor-like growth factor have a poor prognosis. Here we assessed the pharmacokinetics and tumour-inhibiting effects of cross-reacting material 197, produced
Autor:
Fusanori, Yotsumoto, Satoshi, Fukagawa, Kohei, Miyata, Sung Ouk, Nam, Takahiro, Katsuda, Daisuke, Miyahara, Takashi, Odawara, Sadao, Manabe, Toyokazu, Ishikawa, Shin'ichiro, Yasunaga, Shingo, Miyamoto
Publikováno v:
Anticancer research. 37(7)
Advanced lung cancer is one of the most lethal malignancies. Many anticancer agents have been developed for lung cancer with epidermal growth factor receptor (EGFR) mutations, but its prognosis remains extremely poor. The development of molecularly-t